Other
LUM Imaging System
LUM Imaging System is an intervention with 6 clinical trials. Historical success rate of 40.0%.
Total Trials
6
Max Phase
—
Type
COMBINATION PRODUCT
Molecule
—
Success Metrics
Clinical Success Rate
40.0%
Based on 2 completed trials
Completion Rate
40%(2/5)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
3(50%)
Phase Distribution
Ph phase_2
2
33%
Ph not_applicable
2
33%
Ph phase_1
2
33%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
2(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
33.3%
2 of 6 finished
Non-Completion Rate
66.7%
4 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(2)
Terminated(4)
Detailed Status
Terminated3
Completed2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
40.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (33.3%)
Phase 22 (33.3%)
N/A2 (33.3%)
Trials by Status
terminated350%
withdrawn117%
completed233%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_1
Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies
NCT03834272
terminatedphase_2
Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
NCT04440982
terminatednot_applicable
Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
NCT03717142
withdrawnnot_applicable
Feasibility Study of LUM Imaging System for Pancreatic Cancer
NCT04276909
completedphase_2
Intraoperative Detection of Residual Cancer in Breast Cancer
NCT03321929
Clinical Trials (6)
Showing 6 of 6 trials
NCT03834272Phase 1
Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies
NCT04440982Phase 2
Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
NCT03717142Not Applicable
Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
NCT04276909Not Applicable
Feasibility Study of LUM Imaging System for Pancreatic Cancer
NCT03321929Phase 2
Intraoperative Detection of Residual Cancer in Breast Cancer
NCT03441464Phase 1
Feasibility of the LUM Imaging System for Detection of Prostate Cancer
All 6 trials loaded
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 6